← Back to Clinical Trials
Recruiting NCT03311776

BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Pancreatic Cancer
Sponsor Inna Chen, MD
Study Type OBSERVATIONAL
Phase N/A
Enrollment 5,000
Sex ALL
Min Age 19 Years
Max Age N/A
Start Date 2008-07-03
Completion 2035-07-02

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

No validated biomarkers to identify PC at an early stage and to predict treatment outcomes in the individual patient exist. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.

Eligibility Criteria

Inclusion Criteria: * Age \> 18 years * Histologically verified PC (ductal adenocarcinoma) or ampullary adenocarcinoma in a resected specimen; or histopathological confirmation of carcinoma in patients not undergoing surgery in the setting of clinical and radiological characteristics which, together with the pathology, are consistent with a diagnosis of PC independently of stage Exclusion Criteria: • None

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE PANCREATIC CANCER TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}